Insider Trading disclosures for KalVista Pharmaceuticals Inc

The latest disclosure was made by Benjamin L. Palleiko in KalVista Pharmaceuticals Inc where a trade of 6,669 Common Stock done at an average price of $12.0 was reported to US exchanges on March 6, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 11.97 per share.	06 Mar 2025	6,669	287,811 (1%)	0%	12.0	79,828	Common Stock
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	15,625	187,501	-		-	Restricted Stock Unit
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Mar 2025	15,625	294,480 (1%)	0%		-	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Sale of securities on an exchange or to another person at price $ 10.02 per share.	22 Feb 2025	2,394	102,940 (0%)	0%	10.0	23,988	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Feb 2025	5,000	105,334 (0%)	0%		-	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Feb 2025	5,000	65,000	-		-	Restricted Stock Unit
Paul K. Audhya	CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2025	100,000	100,000	-		-	Restricted Stock Units
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2025	372,000	372,000	-		-	Restricted Stock Unit
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Feb 2025	3,125	40,625	-		-	Restricted Stock Unit
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2025	60,000	60,000	-		-	Restricted Stock Unit
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Sale of securities on an exchange or to another person at price $ 10.02 per share.	21 Feb 2025	1,918	93,952 (0%)	0%	10.0	19,218	Common Stock
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Feb 2025	3,125	95,870 (0%)	0%		-	Common Stock
Brian Piekos	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2025	80,000	80,000	-		-	Restricted Stock Unit
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2025	6,944	20,834	-		-	Restricted Stock Unit
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2025	9,363	283,959 (1%)	0%		-	Common Stock
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 9.82 per share.	17 Feb 2025	5,104	278,855 (1%)	0%	9.8	50,143	Common Stock
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2025	2,419	12,094	-		-	Restricted Stock Unit
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2025	4,204	95,346 (0%)	0%		-	Common Stock
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Sale of securities on an exchange or to another person at price $ 9.82 per share.	17 Feb 2025	2,601	92,745 (0%)	0%	9.8	25,553	Common Stock
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2025	2,430	7,292	-		-	Restricted Stock Unit
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2025	6,447	103,459 (0%)	0%		-	Common Stock
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2025	1,774	8,869	-		-	Restricted Stock Unit
Paul K. Audhya	CHIEF MEDICAL OFFICER	Sale of securities on an exchange or to another person at price $ 9.82 per share.	17 Feb 2025	3,125	100,334 (0%)	0%	9.8	30,701	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2025	2,419	12,094	-		-	Restricted Stock Unit
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2025	4,028	12,084	-		-	Restricted Stock Unit
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 9.75 per share.	06 Dec 2024	7,627	274,596 (1%)	0%	9.7	74,363	Common Stock
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Dec 2024	15,625	203,126	-		-	Restricted Stock Unit
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Dec 2024	15,625	282,223 (1%)	0%		-	Common Stock
Laurence E. Reid	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Nov 2024	17,000	17,000	-		-	Stock Option (Right to Buy)
Yea Christopher M.	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Nov 2024	3,125	93,105 (0%)	0%		-	Common Stock
M. Christopher Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Nov 2024	3,125	43,750	-		-	Restricted Stock Unit
Yea M. Christopher	CHIEF DEVELOPMENT OFFICER	Sale of securities on an exchange or to another person at price $ 9.87 per share.	22 Nov 2024	1,963	91,142 (0%)	0%	9.9	19,378	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Nov 2024	5,000	99,199 (0%)	0%		-	Common Stock
Audhya Paul K.	CHIEF MEDICAL OFFICER	Sale of securities on an exchange or to another person at price $ 9.87 per share.	22 Nov 2024	2,187	97,012 (0%)	0%	9.9	21,586	Common Stock
Audhya K. Paul	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Nov 2024	5,000	70,000	-		-	Restricted Stock Unit
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2024	11,496	97,172 (0%)	0%		-	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2024	18,531	102,276 (0%)	0%		-	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2024	2,419	14,513	-		-	Restricted Stock Unit
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2024	4,028	16,112	-		-	Restricted Stock Unit
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2024	12,084	0	-		-	Performance Stock Units
Paul K. Audhya	CHIEF MEDICAL OFFICER	Sale of securities on an exchange or to another person at price $ 9.26 per share.	17 Nov 2024	8,077	94,199 (0%)	0%	9.3	74,766	Common Stock
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Sale of securities on an exchange or to another person at price $ 9.26 per share.	17 Nov 2024	7,192	89,980 (0%)	0%	9.3	66,573	Common Stock
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2024	1,774	10,643	-		-	Restricted Stock Unit
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2024	2,431	9,722	-		-	Restricted Stock Unit
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2024	7,291	0	-		-	Performance Stock Units
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2024	20,834	0	-		-	Performance Stock Units
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2024	30,198	280,998 (1%)	0%		-	Common Stock
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 9.26 per share.	17 Nov 2024	14,400	266,598 (1%)	0%	9.3	133,294	Common Stock
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2024	2,419	14,513	-		-	Restricted Stock Unit
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2024	6,945	27,778	-		-	Restricted Stock Unit
Patrick Treanor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2024	10,000	10,000	-		-	Stock Option (Right to Buy)
William Carl Fairey	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2024	10,000	10,000	-		-	Stock Option (Right to Buy)
Nancy Stuart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2024	10,000	10,000	-		-	Stock Option (Right to Buy)
Edward W. Unkart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2024	10,000	10,000	-		-	Stock Option (Right to Buy)
Brian J.G. Pereira	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2024	10,000	10,000	-		-	Stock Option (Right to Buy)
Brian Piekos	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Sep 2024	100,000	100,000	-		-	Employee Stock Option (right to buy)
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Sep 2024	15,625	258,152 (1%)	0%		-	Common Stock
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Sep 2024	15,625	218,751	-		-	Restricted Stock Unit
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 12.19 per share.	06 Sep 2024	7,352	250,800 (1%)	0%	12.2	89,622	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Aug 2024	5,000	85,880 (0%)	0%		-	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Sale of securities on an exchange or to another person at price $ 12.40 per share.	22 Aug 2024	2,135	83,745 (0%)	0%	12.4	26,474	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Aug 2024	5,000	75,000	-		-	Restricted Stock Unit
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Sale of securities on an exchange or to another person at price $ 12.40 per share.	22 Aug 2024	1,916	85,676 (0%)	0%	12.4	23,758	Common Stock
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Aug 2024	3,125	46,875	-		-	Restricted Stock Unit
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Aug 2024	3,125	87,592 (0%)	0%		-	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Sale of securities on an exchange or to another person at price $ 12.01 per share.	17 Aug 2024	7,973	80,880 (0%)	0%	12.0	95,782	Common Stock
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2024	30,195	256,742 (1%)	0%		-	Common Stock
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2024	20,833	20,834	-		-	Performance Stock Units
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2024	6,944	34,723	-		-	Restricted Stock Unit
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2024	2,418	16,932	-		-	Restricted Stock Unit
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 12.01 per share.	17 Aug 2024	14,215	242,527 (1%)	0%	12.0	170,769	Common Stock
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Sale of securities on an exchange or to another person at price $ 12.01 per share.	17 Aug 2024	7,102	84,467 (0%)	0%	12.0	85,318	Common Stock
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2024	7,292	7,291	-		-	Performance Stock Units
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2024	2,430	12,153	-		-	Restricted Stock Unit
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2024	1,773	12,417	-		-	Restricted Stock Unit
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2024	11,495	91,569 (0%)	0%		-	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2024	2,418	16,932	-		-	Restricted Stock Unit
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2024	12,083	12,084	-		-	Performance Stock Units
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2024	4,027	20,140	-		-	Restricted Stock Unit
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2024	18,528	88,853 (0%)	0%		-	Common Stock
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Jun 2024	15,625	232,012 (1%)	0%		-	Common Stock
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 11.53 per share.	06 Jun 2024	7,465	224,547 (1%)	0%	11.5	86,068	Common Stock
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Jun 2024	15,625	234,375	-		-	Restricted Stock Unit
Paul K. Audhya	CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2024	80,000	80,000	-		-	Restricted Stock Units
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 May 2024	50,000	50,000	-		-	Restricted Stock Units
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	4,028	24,167	-		-	Restricted Stock Unit
Paul K. Audhya	CHIEF MEDICAL OFFICER	Sale of securities on an exchange or to another person at price $ 11.76 per share.	17 May 2024	13,175	70,325 (0%)	0%	11.8	154,997	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	30,614	83,500 (0%)	0%		-	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	12,083	24,167	-		-	Performance Stock Units
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	20,833	41,667	-		-	Performance Stock Units
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	51,031	238,346 (1%)	0%		-	Common Stock
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 11.76 per share.	17 May 2024	21,959	216,387 (1%)	0%	11.8	258,337	Common Stock
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	2,419	19,350	-		-	Restricted Stock Unit
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	6,945	41,667	-		-	Restricted Stock Unit
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	20,834	0	-		-	Performance Stock Units
Edward P. Feener	CHIEF SCIENTIFIC OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	7,292	14,583	-		-	Performance Stock Units
Edward P. Feener	CHIEF SCIENTIFIC OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	18,789	80,946 (0%)	0%		-	Common Stock
Edward P. Feener	CHIEF SCIENTIFIC OFFICER	Sale of securities on an exchange or to another person at price $ 11.76 per share.	17 May 2024	8,088	72,858 (0%)	0%	11.8	95,151	Common Stock
Edward P. Feener	CHIEF SCIENTIFIC OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	1,774	14,190	-		-	Restricted Stock Unit
Edward P. Feener	CHIEF SCIENTIFIC OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	2,431	14,583	-		-	Restricted Stock Unit
Edward P. Feener	CHIEF SCIENTIFIC OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	7,292	0	-		-	Performance Stock Units
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	18,789	91,684 (0%)	0%		-	Common Stock
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	7,292	14,583	-		-	Performance Stock Units
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	7,292	0	-		-	Performance Stock Units
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	2,431	14,583	-		-	Restricted Stock Unit
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	1,774	14,190	-		-	Restricted Stock Unit
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Sale of securities on an exchange or to another person at price $ 11.76 per share.	17 May 2024	11,610	80,074 (0%)	0%	11.8	136,586	Common Stock
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	12,084	0	-		-	Performance Stock Units
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 May 2024	2,419	19,350	-		-	Restricted Stock Unit
William Carl Fairey	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Apr 2024	17,000	17,000	-		-	Stock Option (Right to Buy)
Benjamin L. Palleiko	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Mar 2024	250,000	250,000	-		-	Restricted Stock Unit
Yea Christopher M.	CHIEF DEVELOPMENT OFFICER	Sale of securities on an exchange or to another person at price $ 14.11 per share.	17 Feb 2024	12,053	72,895 (0%)	0%	14.1	170,124	Common Stock
Andrew Crockett Thomas	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	20,833	20,834	-		-	Performance Stock Units
Crockett Andrew Thomas	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	5,805	52,245	-		-	Restricted Stock Unit
P. Feener Edward	CHIEF SCIENTIFIC OFFICER	Sale of securities on an exchange or to another person at price $ 14.11 per share.	17 Feb 2024	8,397	82,048 (0%)	0%	14.1	118,522	Common Stock
Crockett Andrew Thomas	Director, CEO	Sale of securities on an exchange or to another person at price $ 14.11 per share.	17 Feb 2024	24,888	211,203 (1%)	0%	14.1	351,289	Common Stock
Palleiko L. Benjamin	CFO, CBO	Sale of securities on an exchange or to another person at price $ 14.11 per share.	17 Feb 2024	22,802	187,315 (1%)	0%	14.1	321,846	Common Stock
Edward Feener P.	CHIEF SCIENTIFIC OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	2,430	17,014	-		-	Restricted Stock Unit
Crockett Thomas Andrew	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	20,833	62,500	-		-	Performance Stock Units
Feener Edward P.	CHIEF SCIENTIFIC OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	18,788	90,445 (0%)	0%		-	Common Stock
Crockett Thomas Andrew	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	54,415	236,091 (1%)	0%		-	Common Stock
K. Audhya Paul	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	2,419	21,769	-		-	Restricted Stock Unit
Andrew Thomas Crockett	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	6,944	48,612	-		-	Restricted Stock Unit
Yea Christopher M.	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	2,430	17,014	-		-	Restricted Stock Unit
Feener P. Edward	CHIEF SCIENTIFIC OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	7,292	21,875	-		-	Performance Stock Units
Feener P. Edward	CHIEF SCIENTIFIC OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	1,774	15,964	-		-	Restricted Stock Unit
Audhya Paul K.	CHIEF MEDICAL OFFICER	Sale of securities on an exchange or to another person at price $ 14.12 per share.	17 Feb 2024	14,295	52,886 (0%)	0%	14.1	201,774	Common Stock
Edward P. Feener	CHIEF SCIENTIFIC OFFICER	Sale of securities on an exchange or to another person at price $ 14.04 per share.	17 Feb 2024	19,591	62,457 (0%)	0%	14.0	274,991	Common Stock
Benjamin L. Palleiko	CFO, CBO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	2,419	21,769	-		-	Restricted Stock Unit
Palleiko Benjamin L.	CFO, CBO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	51,029	210,117 (1%)	0%		-	Common Stock
M. Christopher Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	1,774	15,964	-		-	Restricted Stock Unit
Paul K. Audhya	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	12,083	36,250	-		-	Performance Stock Units
Christopher Yea M.	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	7,292	7,292	-		-	Performance Stock Units
Audhya K. Paul	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	12,083	12,084	-		-	Performance Stock Units
Edward Feener P.	CHIEF SCIENTIFIC OFFICER	Sale of securities on an exchange or to another person at price $ 14.72 per share.	17 Feb 2024	300	62,157 (0%)	0%	14.7	4,416	Common Stock
Audhya K. Paul	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	30,613	67,181 (0%)	0%		-	Common Stock
M. Christopher Yea	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	18,788	84,948 (0%)	0%		-	Common Stock
Christopher Yea M.	CHIEF DEVELOPMENT OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	7,292	29,167	-		-	Performance Stock Units
Feener Edward P.	CHIEF SCIENTIFIC OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	7,292	7,292	-		-	Performance Stock Units
Palleiko Benjamin L.	CFO, CBO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	20,833	20,834	-		-	Performance Stock Units
Palleiko L. Benjamin	CFO, CBO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	6,944	48,612	-		-	Restricted Stock Unit
K. Audhya Paul	CHIEF MEDICAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	4,028	28,195	-		-	Restricted Stock Unit
L. Palleiko Benjamin	CFO, CBO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2024	20,833	62,500	-		-	Performance Stock Units
Edward Feener P.	CHIEF SCIENTIFIC OFFICER	Sale of securities on an exchange or to another person at price $ 15.01 per share.	14 Feb 2024	28,171	71,657 (0%)	0%	15.0	422,827	Common Stock
Crockett Thomas Andrew	Director, CEO	Sale of securities on an exchange or to another person at price $ 15.01 per share.	14 Feb 2024	58,356	181,676 (1%)	0%	15.0	875,883	Common Stock
Christopher M. Yea	CHIEF DEVELOPMENT OFFICER	Sale of securities on an exchange or to another person at price $ 15.01 per share.	14 Feb 2024	39,886	66,160 (0%)	0%	15.0	598,661	Common Stock
L. Palleiko Benjamin	CFO, CBO	Sale of securities on an exchange or to another person at price $ 15.01 per share.	14 Feb 2024	40,855	159,088 (0%)	0%	15.0	613,205	Common Stock
Palleiko Benjamin L.	CFO, CBO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2024	83,333	83,333	-		-	Performance Stock Units
P. Edward Feener	CHIEF SCIENTIFIC OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2024	29,167	29,167	-		-	Performance Stock Units
Crockett Andrew Thomas	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2024	83,333	83,333	-		-	Performance Stock Units
P. Edward Feener	CHIEF SCIENTIFIC OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2024	60,000	99,828 (0%)	0%		-	Common Stock
M. Yea Christopher	CHIEF DEVELOPMENT OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2024	60,000	106,046 (0%)	0%		-	Common Stock
M. Yea Christopher	CHIEF DEVELOPMENT OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2024	29,167	29,167	-		-	Performance Stock Units
Benjamin Palleiko L.	CFO, CBO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2024	87,500	199,943 (1%)	0%		-	Common Stock
Audhya Paul K.	CHIEF MEDICAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2024	48,333	48,333	-		-	Performance Stock Units
Thomas Andrew Crockett	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2024	122,500	240,032 (1%)	0%		-	Common Stock
Andrew Thomas Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 16.18 per share.	01 Feb 2024	9,300	118,232 (0%)	0%	16.2	150,428	Common Stock
Andrew Crockett Thomas	Director, CEO	Sale of securities on an exchange or to another person at price $ 16.81 per share.	01 Feb 2024	700	117,532 (0%)	0%	16.8	11,770	Common Stock
P. Feener Edward	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 13.03 per share.	11 Jan 2024	22,679	39,828 (0%)	0%	13.0	295,514	Common Stock
P. Feener Edward	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 13.00 per share.	08 Jan 2024	100	62,507 (0%)	0%	13	1,300	Common Stock
P. Edward Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 13.01 per share.	08 Jan 2024	17,221	62,607 (0%)	0%	13.0	224,000	Common Stock
Crockett Andrew Thomas	Director, CEO	Sale of securities on an exchange or to another person at price $ 12.02 per share.	27 Dec 2023	30,000	127,532 (0%)	0%	12.0	360,453	Common Stock
Benjamin L. Palleiko	President, CFO, CBO & Secy	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	20,833	0	-		-	Performance Stock Unit
Benjamin L. Palleiko	President, CFO, CBO & Secy	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	30,195	108,321 (0%)	0%		-	Common Stock
Benjamin L. Palleiko	President, CFO, CBO & Secy	Sale of securities on an exchange or to another person at price $ 10.73 per share.	17 Aug 2023	13,067	95,254 (0%)	0%	10.7	140,192	Common Stock
Benjamin L. Palleiko	President, CFO, CBO & Secy	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	6,944	62,501	-		-	Restricted Stock Unit
Benjamin L. Palleiko	President, CFO, CBO & Secy	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	2,418	26,607	-		-	Restricted Stock Unit
Thomas Andrew Crockett	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	33,582	161,632 (0%)	0%		-	Common Stock
Thomas Andrew Crockett	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	20,833	0	-		-	Performance Stock Unit
Thomas Andrew Crockett	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	5,805	63,855	-		-	Restricted Stock Unit
Thomas Andrew Crockett	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	6,944	62,501	-		-	Restricted Stock Unit
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 10.73 per share.	17 Aug 2023	14,876	146,756 (0%)	0%	10.7	159,602	Common Stock
Edward P. Feener	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	2,430	21,875	-		-	Restricted Stock Unit
Edward P. Feener	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	11,494	78,265 (0%)	0%		-	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 10.73 per share.	17 Aug 2023	4,976	73,289 (0%)	0%	10.7	53,386	Common Stock
Edward P. Feener	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	1,773	19,512	-		-	Restricted Stock Unit
Edward P. Feener	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	7,291	0	-		-	Performance Stock Unit
Christopher M. Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	7,291	0	-		-	Performance Stock Unit
Christopher M. Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	11,494	48,804 (0%)	0%		-	Common Stock
Christopher M. Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 10.73 per share.	17 Aug 2023	7,142	41,662 (0%)	0%	10.7	76,624	Common Stock
Christopher M. Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	1,773	19,512	-		-	Restricted Stock Unit
Christopher M. Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	2,430	21,875	-		-	Restricted Stock Unit
Paul K. Audhya	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	12,083	0	-		-	Performance Stock Unit
Paul K. Audhya	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	18,529	34,043 (0%)	0%		-	Common Stock
Paul K. Audhya	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 10.73 per share.	17 Aug 2023	8,020	26,023 (0%)	0%	10.7	86,045	Common Stock
Paul K. Audhya	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	2,418	26,607	-		-	Restricted Stock Unit
Paul K. Audhya	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2023	4,028	36,251	-		-	Restricted Stock Unit
Benjamin L. Palleiko	President, CFO, CBO & Secy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2023	40,000	40,000	-		-	Employee Stock Option (Right to Buy)
Benjamin L. Palleiko	President, CFO, CBO & Secy	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2023	6,944	76,390	-		-	Restricted Stock Unit
Thomas Andrew Crockett	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2023	6,944	76,390	-		-	Restricted Stock Unit
Edward P. Feener	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2023	2,430	26,736	-		-	Restricted Stock Unit
Christopher M. Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2023	2,430	26,736	-		-	Restricted Stock Unit
Paul K. Audhya	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Feb 2023	4,027	44,307	-		-	Restricted Stock Unit
Christopher M. Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Nov 2022	1,774	35,371 (0%)	0%		-	Common Stock
Christopher M. Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Nov 2022	1,774	24,833	-		-	Restricted Stock Unit
Christopher M. Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 5.44 per share.	21 Nov 2022	1,139	34,232 (0%)	0%	5.4	6,196	Common Stock
Benjamin L. Palleiko	CFO, CBO & Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2022	2,419	69,112 (0%)	0%		-	Common Stock
Benjamin L. Palleiko	CFO, CBO & Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2022	2,419	33,863	-		-	Restricted Stock Unit
Benjamin L. Palleiko	CFO, CBO & Secretary	Sale of securities on an exchange or to another person at price $ 5.44 per share.	17 Nov 2022	722	68,390 (0%)	0%	5.4	3,928	Common Stock
Thomas Andrew Crockett	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2022	5,805	116,663 (0%)	0%		-	Common Stock
Thomas Andrew Crockett	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2022	5,805	81,270	-		-	Restricted Stock Unit
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 5.44 per share.	17 Nov 2022	1,785	114,878 (0%)	0%	5.4	9,710	Common Stock
Edward P. Feener	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2022	1,774	62,906 (0%)	0%		-	Common Stock
Edward P. Feener	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2022	1,774	24,833	-		-	Restricted Stock Unit
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 5.44 per share.	17 Nov 2022	530	62,376 (0%)	0%	5.4	2,883	Common Stock
Paul K. Audhya	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2022	2,419	6,668 (0%)	0%		-	Common Stock
Paul K. Audhya	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Nov 2022	2,419	33,863	-		-	Restricted Stock Unit
Paul K. Audhya	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 5.44 per share.	17 Nov 2022	722	5,946 (0%)	0%	5.4	3,928	Common Stock
Albert Cha	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Oct 2022	10,000	10,000	-		-	Employee Stock Option (right to buy)
Brian J.G. Pereira	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Oct 2022	10,000	10,000	-		-	Employee Stock Option (right to buy)
Edward W. Unkart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Oct 2022	10,000	10,000	-		-	Employee Stock Option (right to buy)
Nancy Stuart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Oct 2022	10,000	10,000	-		-	Employee Stock Option (right to buy)
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 17.01 per share.	02 Sep 2022	1,320	110,858 (0%)	0%	17.0	22,458	Common Stock
Thomas Andrew Crockett	Director, CEO	Gift of securities by or to the insider at price $ 0.00 per share.	02 Sep 2022	6,500	112,178 (0%)	0%		0	Common Stock
Benjamin L. Palleiko	CFO, CBO & Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2022	2,418	67,418 (0%)	0%		-	Common Stock
Benjamin L. Palleiko	CFO, CBO & Secretary	Sale of securities on an exchange or to another person at price $ 14.96 per share.	17 Aug 2022	725	66,693 (0%)	0%	15.0	10,847	Common Stock
Benjamin L. Palleiko	CFO, CBO & Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2022	2,418	36,282	-		-	Restricted Stock Unit
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 14.96 per share.	17 Aug 2022	1,797	112,178 (0%)	0%	15.0	26,890	Common Stock
Thomas Andrew Crockett	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2022	5,805	91,083	-		-	Restricted Stock Unit
Thomas Andrew Crockett	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2022	5,805	113,975 (0%)	0%		-	Common Stock
Edward P. Feener	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2022	1,773	61,664 (0%)	0%		-	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 14.96 per share.	17 Aug 2022	532	61,132 (0%)	0%	15.0	7,960	Common Stock
Edward P. Feener	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2022	1,773	26,607	-		-	Restricted Stock Unit
Christopher M. Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2022	1,773	34,742 (0%)	0%		-	Common Stock
Christopher M. Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 14.96 per share.	17 Aug 2022	1,145	33,597 (0%)	0%	15.0	17,130	Common Stock
Christopher M. Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2022	1,773	26,607	-		-	Restricted Stock Unit
Paul K. Audhya	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 14.96 per share.	17 Aug 2022	725	1,693 (0%)	0%	15.0	10,847	Common Stock
Paul K. Audhya	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2022	2,418	36,282	-		-	Restricted Stock Unit
Paul K. Audhya	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	17 Aug 2022	2,418	2,418 (0%)	0%		-	Common Stock
Patrick Treanor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 May 2022	17,000	17,000	-		-	Stock Option (right to buy)
Benjamin L. Palleiko	CFO, CBO & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 May 2022	38,700	38,700	-		-	Restricted Stock Units
Benjamin L. Palleiko	CFO, CBO & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 May 2022	25,800	25,800	-		-	Employee Stock Option (Right to Buy)
Thomas Andrew Crockett	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 May 2022	92,880	92,880	-		-	Restricted Stock Units
Thomas Andrew Crockett	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 May 2022	61,920	61,920	-		-	Employee Stock Option (Right to Buy)
Edward P. Feener	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 May 2022	28,380	28,380	-		-	Restricted Stock Units
Edward P. Feener	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 May 2022	18,920	18,920	-		-	Employee Stock Option (Right to Buy)
Christopher M. Yea	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 May 2022	18,920	18,920	-		-	Employee Stock Option (Right to Buy)
Christopher M. Yea	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 May 2022	28,380	28,380	-		-	Restricted Stock Units
Michael David Smith	Senior VP, Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 May 2022	10,320	10,320	-		-	Employee Stock Option (Right to Buy)
Michael David Smith	Senior VP, Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 May 2022	15,480	15,480	-		-	Restricted Stock Units
Paul K. Audhya	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 May 2022	25,800	25,800	-		-	Employee Stock Option (Right to Buy)
Paul K. Audhya	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 May 2022	38,700	38,700	-		-	Restricted Stock Units
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 17.07 per share.	09 Mar 2022	10,000	114,670 (0%)	0%	17.1	170,693	Common Stock
Edward P. Feener	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.07 per share.	07 Jan 2022	33,800	36,034 (0%)	0%	7.1	238,966	Common Stock
Edward P. Feener	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Jan 2022	23,857	27,943	-		-	Employee Stock Option (right to buy)
Edward P. Feener	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Jan 2022	33,800	0	-		-	Employee Stock Option (right to buy)
Edward P. Feener	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.21 per share.	07 Jan 2022	23,857	59,891 (0%)	0%	8.2	195,866	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 17.18 per share.	01 Oct 2021	10,000	124,670 (0%)	0%	17.2	171,841	Common Stock
Albert Cha	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2021	10,000	10,000	-		-	Director Stock Option (Right to Buy)
Brian J.G. Pereira	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2021	10,000	10,000	-		-	Director Stock Option (Right to Buy)
Edward W. Unkart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2021	10,000	10,000	-		-	Director Stock Option (Right to Buy)
Daniel B. Soland	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2021	10,000	10,000	-		-	Director Stock Option (Right to Buy)
Martin William Edwards	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2021	10,000	10,000	-		-	Director Stock Option (Right to Buy)
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 20.52 per share.	02 Aug 2021	6,000	8,234 (0%)	0%	20.5	123,134	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 20.52 per share.	02 Aug 2021	5,000	37,969 (0%)	0%	20.5	102,579	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 23.88 per share.	01 Jul 2021	4,350	140,320 (0%)	0%	23.9	103,872	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 24.35 per share.	01 Jul 2021	5,650	134,670 (0%)	0%	24.4	137,605	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 30.04 per share.	17 Jun 2021	1,067	144,670 (0%)	0%	30.0	32,051	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 26.81 per share.	01 Jun 2021	25,786	22,448 (0%)	0%	26.8	691,284	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 27.05 per share.	01 Jun 2021	1,062	14,234 (0%)	0%	27.0	28,723	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 26.33 per share.	01 Jun 2021	7,138	15,296 (0%)	0%	26.3	187,973	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 27.21 per share.	01 Jun 2021	14	22,434 (0%)	0%	27.2	381	Common Stock
Michael David Smith	Senior VP, Development	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2021	7,500	22,596	-		-	Stock Option (right to buy)
Michael David Smith	Senior VP, Development	Sale of securities on an exchange or to another person at price $ 26.83 per share.	01 Jun 2021	7,500	0 (0%)	0%	26.8	201,221	Common Stock
Michael David Smith	Senior VP, Development	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.39 per share.	01 Jun 2021	7,500	7,500 (0%)	0%	8.4	62,925	Common Stock
Benjamin L. Palleiko	CFO, CBO & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 May 2021	75,000	75,000	-		-	Employee Stock Option (Right to Buy)
Andreas Maetzel	Senior Vice President, Medical	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 May 2021	25,000	25,000	-		-	Employee Stock Option (Right to Buy)
Thomas Andrew Crockett	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 May 2021	200,000	200,000	-		-	Employee Stock Option (Right to Buy)
Thomas Andrew Crockett	Director, CEO	Gift of securities by or to the insider at price $ 0.00 per share.	26 May 2021	4,750	154,670 (0%)	0%		0	Common Stock
Edward P. Feener	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 May 2021	60,000	60,000	-		-	Employee Stock Option (Right to Buy)
Christopher Yea	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 May 2021	60,000	60,000	-		-	Employee Stock Option (Right to Buy)
Michael David Smith	Senior VP, Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 May 2021	35,000	35,000	-		-	Employee Stock Option (Right to Buy)
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 24.84 per share.	03 May 2021	6,000	48,234 (0%)	0%	24.8	149,051	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 24.84 per share.	03 May 2021	5,000	42,969 (0%)	0%	24.8	124,197	Common Stock
Paul K. Audhya	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2021	100,000	100,000	-		-	Employee Stock Option (right to buy)
Michael David Smith	Senior VP, Development	Sale of securities on an exchange or to another person at price $ 25.76 per share.	28 Apr 2021	10,014	0 (0%)	0%	25.8	257,983	Common Stock
Michael David Smith	Senior VP, Development	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Apr 2021	10,014	30,096	-		-	Stock Option (right to buy)
Michael David Smith	Senior VP, Development	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.39 per share.	28 Apr 2021	10,014	10,014 (0%)	0%	8.4	84,017	Common Stock
Andreas Maetzel	Senior Vice President, Medical	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Apr 2021	14,662	6,038	-		-	Employee Stock Option (right to buy)
Andreas Maetzel	Senior Vice President, Medical	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.91 per share.	27 Apr 2021	11,017	11,017 (0%)	0%	7.9	87,144	Common Stock
Andreas Maetzel	Senior Vice President, Medical	Sale of securities on an exchange or to another person at price $ 25.79 per share.	27 Apr 2021	11,017	0 (0%)	0%	25.8	284,163	Common Stock
Andreas Maetzel	Senior Vice President, Medical	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.91 per share.	27 Apr 2021	36,127	36,127 (0%)	0%	7.9	285,765	Common Stock
Andreas Maetzel	Senior Vice President, Medical	Sale of securities on an exchange or to another person at price $ 25.50 per share.	27 Apr 2021	10,620	25,507 (0%)	0%	25.5	270,810	Common Stock
Andreas Maetzel	Senior Vice President, Medical	Sale of securities on an exchange or to another person at price $ 25.25 per share.	27 Apr 2021	15,000	10,507 (0%)	0%	25.3	378,783	Common Stock
Andreas Maetzel	Senior Vice President, Medical	Sale of securities on an exchange or to another person at price $ 25.54 per share.	27 Apr 2021	10,000	507 (0%)	0%	25.5	255,387	Common Stock
Andreas Maetzel	Senior Vice President, Medical	Sale of securities on an exchange or to another person at price $ 25.65 per share.	27 Apr 2021	507	0 (0%)	0%	25.7	13,005	Common Stock
Andreas Maetzel	Senior Vice President, Medical	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.91 per share.	27 Apr 2021	12,856	12,856 (0%)	0%	7.9	101,691	Common Stock
Andreas Maetzel	Senior Vice President, Medical	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.21 per share.	27 Apr 2021	14,662	27,518 (0%)	0%	8.2	120,375	Common Stock
Andreas Maetzel	Senior Vice President, Medical	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.08 per share.	27 Apr 2021	13,368	40,886 (0%)	0%	16.1	214,957	Common Stock
Andreas Maetzel	Senior Vice President, Medical	Sale of securities on an exchange or to another person at price $ 25.04 per share.	27 Apr 2021	40,886	0 (0%)	0%	25.0	1,023,589	Common Stock
Andreas Maetzel	Senior Vice President, Medical	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Apr 2021	11,017	48,983	-		-	Employee Stock Option (right to buy)
Andreas Maetzel	Senior Vice President, Medical	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Apr 2021	36,127	12,856	-		-	Employee Stock Option (right to buy)
Andreas Maetzel	Senior Vice President, Medical	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Apr 2021	12,856	0	-		-	Employee Stock Option (right to buy)
Andreas Maetzel	Senior Vice President, Medical	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Apr 2021	13,368	7,332	-		-	Employee Stock Option (right to buy)
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 28.11 per share.	01 Apr 2021	800	159,420 (0%)	0%	28.1	22,490	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 27.48 per share.	01 Apr 2021	8,500	160,220 (0%)	0%	27.5	233,590	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 26.22 per share.	01 Apr 2021	700	168,720 (0%)	0%	26.2	18,356	Common Stock
Nancy Stuart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Mar 2021	14,000	14,000	-		-	Employee Stock Option (Right to Buy)
Benjamin L. Palleiko	CFO, CBO & Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.74 per share.	23 Feb 2021	29,642	94,642 (0%)	0%	6.7	199,787	Common Stock
Benjamin L. Palleiko	CFO, CBO & Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Feb 2021	29,642	29,611	-		-	Employee Stock Option (right to buy)
Benjamin L. Palleiko	CFO, CBO & Secretary	Sale of securities on an exchange or to another person at price $ 31.77 per share.	23 Feb 2021	1,256	65,000 (0%)	0%	31.8	39,908	Common Stock
Benjamin L. Palleiko	CFO, CBO & Secretary	Sale of securities on an exchange or to another person at price $ 33.06 per share.	23 Feb 2021	5,293	66,256 (0%)	0%	33.1	174,975	Common Stock
Benjamin L. Palleiko	CFO, CBO & Secretary	Sale of securities on an exchange or to another person at price $ 33.73 per share.	23 Feb 2021	22,093	71,549 (0%)	0%	33.7	745,274	Common Stock
Benjamin L. Palleiko	CFO, CBO & Secretary	Sale of securities on an exchange or to another person at price $ 35.40 per share.	23 Feb 2021	1,000	93,642 (0%)	0%	35.4	35,404	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 31.87 per share.	23 Feb 2021	707	169,420 (0%)	0%	31.9	22,531	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 35.40 per share.	23 Feb 2021	500	178,920 (1%)	0%	35.4	17,700	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 33.73 per share.	23 Feb 2021	7,218	171,702 (0%)	0%	33.7	243,430	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 32.94 per share.	23 Feb 2021	1,575	170,127 (0%)	0%	32.9	51,877	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 33.72 per share.	23 Feb 2021	23,441	60,505 (0%)	0%	33.7	790,534	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 31.73 per share.	23 Feb 2021	800	54,234 (0%)	0%	31.7	25,384	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 32.97 per share.	23 Feb 2021	5,471	55,034 (0%)	0%	33.0	180,400	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 35.19 per share.	23 Feb 2021	1,288	83,946 (0%)	0%	35.2	45,325	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 31.87 per share.	23 Feb 2021	500	47,969 (0%)	0%	31.9	15,933	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 32.94 per share.	23 Feb 2021	3,311	48,469 (0%)	0%	32.9	109,059	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 33.74 per share.	23 Feb 2021	10,389	51,780 (0%)	0%	33.7	350,572	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 35.39 per share.	23 Feb 2021	800	62,169 (0%)	0%	35.4	28,314	Common Stock
Benjamin L. Palleiko	CFO, CBO & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2021	20,000	20,000	-		-	Stock Option (right to buy)
Benjamin L. Palleiko	CFO, CBO & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2021	32,500	65,000 (0%)	0%		0	Common Stock
Benjamin L. Palleiko	CFO, CBO & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2021	37,500	37,500	-		-	Stock Option (right to buy)
Andreas Maetzel	Senior Vice President, Medical	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2021	10,000	10,000	-		-	Stock Option (right to buy)
Andreas Maetzel	Senior Vice President, Medical	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2021	10,000	10,000	-		-	Stock Option (right to buy)
Thomas Andrew Crockett	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2021	75,000	75,000	-		-	Stock Option (right to buy)
Thomas Andrew Crockett	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2021	40,000	40,000	-		-	Stock Option (right to buy)
Edward P. Feener	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2021	20,000	20,000	-		-	Stock Option (right to buy)
Edward P. Feener	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2021	12,500	85,234 (0%)	0%		0	Common Stock
Edward P. Feener	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2021	22,500	22,500	-		-	Stock Option (right to buy)
Christopher Yea	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2021	31,000	31,000	-		-	Stock Option (right to buy)
Christopher Yea	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2021	20,000	20,000	-		-	Stock Option (right to buy)
Michael David Smith	Senior VP, Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2021	16,500	16,500	-		-	Stock Option (right to buy)
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 18.85 per share.	04 Jan 2021	814	185,420 (1%)	0%	18.9	15,346	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 18.13 per share.	04 Jan 2021	9,186	186,234 (1%)	0%	18.1	166,558	Common Stock
Thomas Andrew Crockett	Director, CEO	Gift of securities by or to the insider at price $ 0.00 per share.	04 Jan 2021	6,000	179,420 (1%)	0%		0	Common Stock
Benjamin L. Palleiko	CFO, CBO & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Dec 2020	85,000	85,000	-		-	Stock Option (right to buy)
Andreas Maetzel	Senior Vice President, Medical	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Dec 2020	20,000	20,000	-		-	Stock Option (right to buy)
Thomas Andrew Crockett	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Dec 2020	140,000	140,000	-		-	Stock Option (right to buy)
Edward P. Feener	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Dec 2020	65,000	65,000	-		-	Stock Option (right to buy)
Christopher Yea	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Dec 2020	80,000	80,000	-		-	Stock Option (right to buy)
Michael David Smith	Senior VP, Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Dec 2020	25,000	25,000	-		-	Stock Option (right to buy)
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 17.14 per share.	02 Nov 2020	6,000	72,734 (0%)	0%	17.1	102,812	Common Stock
Albert Cha	Director	Purchase of securities on an exchange or from another person at price $ 17.17 per share.	30 Oct 2020	68,255	1,090,748 (6%)	0%	17.2	1,171,809	Common Stock
Albert Cha	Director	Purchase of securities on an exchange or from another person at price $ 17.34 per share.	30 Oct 2020	47,431	1,138,179 (6%)	0%	17.3	822,259	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 17.48 per share.	29 Oct 2020	5,000	62,969 (0%)	0%	17.5	87,394	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 17.27 per share.	20 Oct 2020	11,218	222,741 (1%)	0%	17.3	193,786	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 18.01 per share.	20 Oct 2020	4,776	217,965 (1%)	0%	18.0	85,992	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 17.48 per share.	20 Oct 2020	5,800	212,165 (1%)	0%	17.5	101,412	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 18.51 per share.	20 Oct 2020	13,052	199,113 (1%)	0%	18.5	241,641	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 19.01 per share.	20 Oct 2020	3,693	195,420 (1%)	0%	19.0	70,194	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 18.00 per share.	20 Oct 2020	2,300	87,741 (0%)	0%	18.0	41,407	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 17.65 per share.	20 Oct 2020	3,600	84,141 (0%)	0%	17.7	63,554	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 18.75 per share.	20 Oct 2020	5,407	78,734 (0%)	0%	18.7	101,374	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 17.26 per share.	20 Oct 2020	5,600	90,041 (0%)	0%	17.3	96,683	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 17.27 per share.	20 Oct 2020	5,640	76,315 (0%)	0%	17.3	97,419	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 17.68 per share.	20 Oct 2020	3,500	70,513 (0%)	0%	17.7	61,893	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 18.01 per share.	20 Oct 2020	2,302	74,013 (0%)	0%	18.0	41,467	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 19.02 per share.	20 Oct 2020	2,544	67,969 (0%)	0%	19.0	48,389	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 17.00 per share.	16 Oct 2020	993	95,641 (0%)	0%	17	16,881	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 17.00 per share.	16 Oct 2020	914	81,955 (0%)	0%	17.0	15,539	Common Stock
Albert Cha	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2020	7,000	7,000	-		-	Director Stock Option (right to buy)
Brian J.G. Pereira	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2020	7,000	7,000	-		-	Director Stock Option (right to buy)
Arnold L. Oronsky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2020	7,000	7,000	-		-	Director Stock Option (right to buy)
Edward W. Unkart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2020	7,000	7,000	-		-	Director Stock Option (right to buy)
Daniel B. Soland	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2020	7,000	7,000	-		-	Director Stock Option (right to buy)
Daniel B. Soland	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2020	7,000	7,000	-		-	Director Stock Option (right to buy)
Martin William Edwards	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2020	7,000	7,000	-		-	Director Stock Option (right to buy)
Thomas Andrew Crockett	Director, CEO	Gift of securities by or to the insider at price $ 0.00 per share.	29 Apr 2020	3,000	233,959 (1%)	0%		0	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 17.01 per share.	29 Apr 2020	1,261	236,959 (1%)	0%	17.0	21,444	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 17.05 per share.	05 Feb 2020	200	238,220 (1%)	0%	17.1	3,410	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 17.11 per share.	05 Feb 2020	100	96,634 (0%)	0%	17.1	1,711	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 17.10 per share.	05 Feb 2020	100	82,869 (0%)	0%	17.1	1,710	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 17.02 per share.	20 Dec 2019	2,300	238,420 (1%)	0%	17.0	39,150	Common Stock
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Dec 2019	2,646	85,615 (0%)	0%	0.0	11	Common Stock
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Dec 2019	2,646	87,390	-		-	Employee Stock Option (Right to Buy)
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 17.02 per share.	20 Dec 2019	2,646	82,969 (0%)	0%	17.0	45,025	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 17.00 per share.	12 Dec 2019	100	248,320 (1%)	0%	17	1,700	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 17.06 per share.	12 Dec 2019	5,400	240,720 (1%)	0%	17.1	92,116	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 17.06 per share.	12 Dec 2019	2,200	246,120 (1%)	0%	17.1	37,536	Common Stock
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Dec 2019	199	94,546	-		-	Employee Stock Option (Right to Buy)
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 17.05 per share.	12 Dec 2019	3,010	82,969 (0%)	0%	17.0	51,318	Common Stock
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Dec 2019	3,010	85,979 (0%)	0%	0.0	13	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 17.05 per share.	12 Dec 2019	1,500	82,969 (0%)	0%	17.0	25,568	Common Stock
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Dec 2019	1,500	84,469 (0%)	0%	0.0	6	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 17.00 per share.	12 Dec 2019	199	82,969 (0%)	0%	17	3,383	Common Stock
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.01 per share.	12 Dec 2019	199	83,168 (0%)	0%	0.0	1	Common Stock
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Dec 2019	3,010	90,036	-		-	Employee Stock Option (Right to Buy)
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Dec 2019	1,500	93,046	-		-	Employee Stock Option (Right to Buy)
Albert Cha	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Oct 2019	7,000	7,000	-		-	Director Stock Option (Right to Buy)
Arnold L. Oronsky	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Oct 2019	7,000	7,000	-		-	Director Stock Option (Right to Buy)
Edward W. Unkart	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Oct 2019	7,000	7,000	-		-	Director Stock Option (Right to Buy)
Daniel B. Soland	None	Purchase of securities on an exchange or from another person at price $ 11.87 per share.	26 Sep 2019	7,962	10,000 (0%)	0%	11.9	94,498	Common Stock
Daniel B. Soland	None	Purchase of securities on an exchange or from another person at price $ 11.90 per share.	26 Sep 2019	2,038	2,038 (0%)	0%	11.9	24,252	Common Stock
Albert Cha	None	Purchase of securities on an exchange or from another person at price $ 16.83 per share.	26 Jul 2019	21,942	997,763 (5%)	0%	16.8	369,317	Common Stock
Albert Cha	None	Purchase of securities on an exchange or from another person at price $ 17.13 per share.	26 Jul 2019	5,137	124,566 (0%)	0%	17.1	88,011	Common Stock
Albert Cha	None	Purchase of securities on an exchange or from another person at price $ 17.13 per share.	26 Jul 2019	24,730	1,022,493 (5%)	0%	17.1	423,692	Common Stock
Albert Cha	None	Purchase of securities on an exchange or from another person at price $ 16.83 per share.	26 Jul 2019	4,558	119,429 (0%)	0%	16.8	76,718	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 18.65 per share.	22 Jul 2019	1,900	96,734 (0%)	0%	18.7	35,439	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 18.57 per share.	22 Jul 2019	1,400	98,634 (0%)	0%	18.6	26,004	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 18.35 per share.	22 Jul 2019	7,355	82,969 (0%)	0%	18.3	134,930	Common Stock
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Jul 2019	7,355	94,745	-		-	Employee Stock Option (Right to Buy)
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Jul 2019	7,355	90,324 (0%)	0%	0.0	32	Common Stock
Albert Cha	None	Purchase of securities on an exchange or from another person at price $ 16.97 per share.	17 Jul 2019	1,060	926,141 (5%)	0%	17.0	17,991	Common Stock
Albert Cha	None	Purchase of securities on an exchange or from another person at price $ 17.84 per share.	17 Jul 2019	49,680	975,821 (5%)	0%	17.8	886,127	Common Stock
Albert Cha	None	Purchase of securities on an exchange or from another person at price $ 17.68 per share.	17 Jul 2019	10,320	114,871 (0%)	0%	17.7	182,453	Common Stock
Albert Cha	None	Purchase of securities on an exchange or from another person at price $ 16.93 per share.	17 Jul 2019	220	104,551 (0%)	0%	16.9	3,724	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 17.04 per share.	15 Jul 2019	10,000	248,510 (1%)	0%	17.0	170,407	Common Stock
Martin William Edwards	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jun 2019	14,000	14,000	-		-	Employee Stock Option (Right to Buy)
Benjamin L. Palleiko	CBO, CFO and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2019	33,750	33,750	-		-	Employee Stock Option (Right to Buy)
Andreas Maetzel	Senior Vice President Medical	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2019	9,000	9,000	-		-	Employee Stock Option (Right to Buy)
Thomas Andrew Crockett	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2019	67,500	67,500	-		-	Employee Stock Option (Right to Buy)
Edward P. Feener	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2019	20,250	20,250	-		-	Employee Stock Option (Right to Buy)
Christopher Yea	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2019	27,900	27,900	-		-	Employee Stock Option (Right to Buy)
Daniel B. Soland	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Apr 2019	14,000	14,000	-		-	Director Stock Option (Right to Buy)
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Apr 2019	7,355	90,324 (0%)	0%	0.0	32	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 26.79 per share.	22 Apr 2019	1,000	82,969 (0%)	0%	26.8	26,786	Common Stock
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Apr 2019	7,355	102,100	-		-	Employee Stock Option (Right to Buy)
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 25.92 per share.	22 Apr 2019	6,355	83,969 (0%)	0%	25.9	164,744	Common Stock
Benjamin L. Palleiko	CBO, CFO and Secretary	Sale of securities on an exchange or to another person at price $ 25.80 per share.	18 Apr 2019	2,000	32,500 (0%)	0%	25.8	51,603	Common Stock
Benjamin L. Palleiko	CBO, CFO and Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.74 per share.	18 Apr 2019	1,073	33,573 (0%)	0%	6.7	7,232	Common Stock
Benjamin L. Palleiko	CBO, CFO and Secretary	Sale of securities on an exchange or to another person at price $ 25.51 per share.	18 Apr 2019	1,073	32,500 (0%)	0%	25.5	27,373	Common Stock
Benjamin L. Palleiko	CBO, CFO and Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Apr 2019	2,000	47,354	-		-	Employee Stock Option (Right to Buy)
Benjamin L. Palleiko	CBO, CFO and Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 Apr 2019	1,073	59,611	-		-	Employee Stock Option (Right to Buy)
Benjamin L. Palleiko	CBO, CFO and Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.39 per share.	18 Apr 2019	2,000	34,500 (0%)	0%	8.4	16,780	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 25.39 per share.	17 Apr 2019	916	100,034 (0%)	0%	25.4	23,260	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 24.77 per share.	17 Apr 2019	3,084	100,950 (0%)	0%	24.8	76,406	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 25.92 per share.	15 Apr 2019	300	258,510 (1%)	0%	25.9	7,777	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 24.76 per share.	15 Apr 2019	9,700	258,810 (1%)	0%	24.8	240,181	Common Stock
Andreas Maetzel	Senior Vice President Medical	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Apr 2019	5,000	60,000	-		-	Employee Stock Option (Right to Buy)
Andreas Maetzel	Senior Vice President Medical	Sale of securities on an exchange or to another person at price $ 30.00 per share.	05 Apr 2019	5,000	0 (0%)	0%	30.0	150,011	Common Stock
Andreas Maetzel	Senior Vice President Medical	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.91 per share.	05 Apr 2019	5,000	5,000 (0%)	0%	7.9	39,550	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 30.16 per share.	14 Mar 2019	3,000	268,510 (1%)	0%	30.2	90,484	Common Stock
Brian J.G. Pereira	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2019	14,000	14,000	-		-	Director Stock Option (Right to Buy)
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 17.06 per share.	25 Jan 2019	5,453	82,969 (0%)	0%	17.1	93,015	Common Stock
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	25 Jan 2019	5,453	109,455	-		-	Employee Stock Option (Right to Buy)
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	25 Jan 2019	5,453	88,422 (0%)	0%	0.0	23	Common Stock
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 17.00 per share.	22 Jan 2019	1,302	82,969 (0%)	0%	17.0	22,139	Common Stock
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Jan 2019	600	114,908	-		-	Employee Stock Option (Right to Buy)
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Jan 2019	1,302	115,508	-		-	Employee Stock Option (Right to Buy)
Christopher Yea	Chief Development Officer	Sale of securities on an exchange or to another person at price $ 17.01 per share.	22 Jan 2019	600	82,969 (0%)	0%	17.0	10,205	Common Stock
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Jan 2019	600	83,569 (0%)	0%	0.0	3	Common Stock
Christopher Yea	Chief Development Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	22 Jan 2019	1,302	84,271 (0%)	0%	0.0	6	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 19.81 per share.	16 Jan 2019	2,300	104,034 (0%)	0%	19.8	45,572	Common Stock
Edward P. Feener	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 19.20 per share.	16 Jan 2019	1,700	106,334 (0%)	0%	19.2	32,637	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 19.28 per share.	14 Jan 2019	9,099	272,411 (1%)	0%	19.3	175,432	Common Stock
Thomas Andrew Crockett	Director, CEO	Sale of securities on an exchange or to another person at price $ 19.86 per share.	14 Jan 2019	901	271,510 (1%)	0%	19.9	17,896	Common Stock
Albert Cha	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2018	7,000	7,000	-		-	Director Stock Option (Right to Buy)
Richard H. Aldrich	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2018	7,000	7,000	-		-	Director Stock Option (Right to Buy)
Arnold L. Oronsky	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2018	7,000	7,000	-		-	Director Stock Option (Right to Buy)
Edward W. Unkart	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2018	7,000	7,000	-		-	Director Stock Option (Right to Buy)
Benjamin L. Palleiko	CFO and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Sep 2018	32,500	32,500 (0%)	0%		0	Common Stock
Benjamin L. Palleiko	CFO and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Sep 2018	52,600	52,600	-		-	Employee Stock Option (Right to Buy)
Andreas Maetzel	Senior Vice President Medical	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Sep 2018	20,700	20,700	-		-	Employee Stock Option (Right to Buy)
Thomas Andrew Crockett	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Sep 2018	150,000	150,000	-		-	Employee Stock Option (Right to Buy)
Edward P. Feener	Chief Scientific Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.05 per share.	18 Sep 2018	2,500	108,034 (0%)	0%	17.1	42,625	Common Stock
Edward P. Feener	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Sep 2018	52,600	52,600	-		-	Employee Stock Option (Right to Buy)
Edward P. Feener	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Sep 2018	12,500	110,534 (0%)	0%		0	Common Stock
Christopher Yea	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Sep 2018	52,600	52,600	-		-	Employee Stock Option (Right to Buy)
Albert Cha	None	Purchase of securities on an exchange or from another person at price $ 17.00 per share.	10 Sep 2018	1,058,824	1,359,149 (7%)	6%	17	18,000,008	Common Stock
Arnold L. Oronsky	None	Purchase of securities on an exchange or from another person at price $ 17.00 per share.	10 Sep 2018	58,824	388,766 (2%)	0%	17	1,000,008	Common Stock
Benjamin L. Palleiko	CFO and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2018	71,700	71,700	-		-	Employee Stock Option (Right to Buy)
Andreas Maetzel	Senior Vice President Medical	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2018	20,700	20,700	-		-	Employee Stock Option (Right to Buy)
Thomas Andrew Crockett	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2018	130,800	130,800	-		-	Employee Stock Option (Right to Buy)
Edward P. Feener	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2018	51,800	51,800	-		-	Employee Stock Option (Right to Buy)
Christopher Yea	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2018	53,500	53,500	-		-	Employee Stock Option (Right to Buy)
Richard H. Aldrich	None	Purchase of securities on an exchange or from another person at price $ 8.61 per share.	12 Oct 2017	565,065	934,484 (8%)	5%	8.6	4,866,961	Common Stock
Rajeev Shah	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 8.50 per share.	12 Oct 2017	850,000	1,441,070 (13%)	7%	8.5	7,225,000	Common Stock
Albert Cha	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Sep 2017	6,000	6,000	-		-	Director Stock Option (Right to Buy)
Richard H. Aldrich	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Sep 2017	6,000	6,000	-		-	Director Stock Option (Right to Buy)
Arnold L. Oronsky	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Sep 2017	6,000	6,000	-		-	Director Stock Option (Right to Buy)
Edward W. Unkart	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Sep 2017	6,000	6,000	-		-	Director Stock Option (Right to Buy)
Rajeev Shah	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Sep 2017	6,000	6,000	-		-	Director Stock Option (Right to Buy)
Joshua Resnick	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Sep 2017	6,000	6,000	-		-	Director Stock Option (Right to Buy)
Benjamin L. Palleiko	CFO and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2017	33,800	33,800	-		-	Employee Stock Option (Right to Buy)
Thomas Andrew Crockett	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2017	187,000	187,000	-		-	Employee Stock Option (Right to Buy)
Edward P. Feener	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2017	33,800	33,800	-		-	Employee Stock Option (Right to Buy)
Christopher Yea	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2017	33,800	33,800	-		-	Employee Stock Option (Right to Buy)
Albert Cha	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Mar 2017	12,000	12,000	-		-	Director Stock Option (Right to Buy)
Richard H. Aldrich	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Mar 2017	12,000	12,000	-		-	Director Stock Option (Right to Buy)
Arnold L. Oronsky	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Mar 2017	12,000	12,000	-		-	Director Stock Option (Right to Buy)
Edward W. Unkart	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Mar 2017	12,000	12,000	-		-	Director Stock Option (Right to Buy)
Rajeev Shah	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Mar 2017	12,000	12,000	-		-	Director Stock Option (Right to Buy)
Joshua Resnick	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Mar 2017	12,000	12,000	-		-	Director Stock Option (Right to Buy)
Andreas Maetzel	Senior Vice President Medical	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Mar 2017	65,000	65,000	-		-	Employee Stock Option (Right to Buy)
Benjamin L. Palleiko	CFO and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Dec 2016	60,684	60,684	-		-	Employee Stock Option (Right to Buy)
Edward P. Feener	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Nov 2016	20,055	20,055	-		-	Employee Stock Option (Right to Buy)
Benjamin L. Palleiko	CFO and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Nov 2016	49,354	49,354	-		-	Employee Stock Option (Right to Buy)
Richard H. Aldrich	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Nov 2016	369,419	369,419	-		-	Common Stock
Steven L. Basta	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Nov 2016	1,125	1,125	-		-	Common Stock
Steven L. Basta	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Nov 2016	1,125	0	-		-	Stock Option (Right to Buy)
Steven L. Basta	None	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	21 Nov 2016	1,026	99	-		-	Common Stock
Steven L. Basta	None		21 Nov 2016	99	0	-		-	Common Stock
David M. Renzi	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Nov 2016	36,640	36,640	-		-	Common Stock
David M. Renzi	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Nov 2016	36,640	0	-		-	Stock Option (Right to Buy)
David M. Renzi	Director, President & CEO		21 Nov 2016	3,186	0	-		-	Common Stock
David M. Renzi	Director, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	21 Nov 2016	33,454	3,186	-		-	Common Stock
Marcee M. Maroney	VP, Clinical Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Nov 2016	1,339	0	-		-	Stock Option (Right to Buy)
Marcee M. Maroney	VP, Clinical Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Nov 2016	4,664	4,664	-		-	Common Stock
Marcee M. Maroney	VP, Clinical Affairs	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	21 Nov 2016	4,255	409	-		-	Common Stock
Marcee M. Maroney	VP, Clinical Affairs		21 Nov 2016	409	0	-		-	Common Stock
Marcee M. Maroney	VP, Clinical Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Nov 2016	2,592	0	-		-	Stock Option (Right to Buy)
Marcee M. Maroney	VP, Clinical Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Nov 2016	732	0	-		-	Stock Option (Right to Buy)
Rajeev Shah	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Nov 2016	591,070	591,070	-		-	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

65.75% Gain from 52W Low

Insider Trading disclosures for KalVista Pharmaceuticals Inc

The latest disclosure was made by Benjamin L. Palleiko in KalVista Pharmaceuticals Inc where a trade of 6,669 Common Stock done at an average price of $12.0 was reported to US exchanges on March 6, 2025.

Screeners based on Insider Trading and SAST parameters